| pubmed-article:19299847 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19299847 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:19299847 | lifeskim:mentions | umls-concept:C0017661 | lld:lifeskim |
| pubmed-article:19299847 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:19299847 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:19299847 | lifeskim:mentions | umls-concept:C1514475 | lld:lifeskim |
| pubmed-article:19299847 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19299847 | pubmed:dateCreated | 2009-3-20 | lld:pubmed |
| pubmed-article:19299847 | pubmed:abstractText | Immunoglobulin A nephropathy (IgAN) is characterised by high variability in clinical course and outcome. Accurate prediction of prognosis is needed to optimise treatment. Urinary alpha1-microglobulin and beta2-microglobulin are markers of tubulointerstitial injury and predict the risk of end-stage renal disease (ESRD) in idiopathic membranous nephropathy. We questioned the relevance of these markers in IgAN. | lld:pubmed |
| pubmed-article:19299847 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19299847 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19299847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19299847 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19299847 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19299847 | pubmed:issn | 0300-2977 | lld:pubmed |
| pubmed-article:19299847 | pubmed:author | pubmed-author:WetzelsJ F... | lld:pubmed |
| pubmed-article:19299847 | pubmed:author | pubmed-author:PetersH P EHP | lld:pubmed |
| pubmed-article:19299847 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:19299847 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19299847 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:19299847 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19299847 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19299847 | pubmed:pagination | 54-61 | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:meshHeading | pubmed-meshheading:19299847... | lld:pubmed |
| pubmed-article:19299847 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19299847 | pubmed:articleTitle | Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. | lld:pubmed |
| pubmed-article:19299847 | pubmed:affiliation | Department of Nephrology, Radboud University Nijmegen Medical Center Nijmegen, Nijmegen, the Netherlands. H.Peters@aig.umcn.nl | lld:pubmed |
| pubmed-article:19299847 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19299847 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
